Ortho Biotech, Inc. Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Bridgewater NJ United States (1990)
Status: Acquired by Centocor (2008) → now Johnson and Johnson (1999)

Organization Overview

First Clinical Trial
1990
NCT00270283
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ortho Biotech Canada | Ortho Biotech Clinical Affairs, L.L.C. | Ortho Biotech Inc | Ortho Biotech Products, L.P.